These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


768 related items for PubMed ID: 16971347

  • 1. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S, Venkatesh P, Mullangi R, Srinivas NR.
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [Abstract] [Full Text] [Related]

  • 2. Effect of pentoxifylline on the pharmacokinetics of rosiglitazone in Wistar rats.
    Varanasi KK, Potharaju S, Rajak S, Veeraraghavan S, Mallick P, Vakkalanka SK.
    Methods Find Exp Clin Pharmacol; 2008 Sep; 30(7):537-42. PubMed ID: 18985182
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
    Zuo Z, Tam YK, Diakur J, Wiebe LI.
    J Pharm Pharm Sci; 2002 Sep; 5(3):292-8. PubMed ID: 12553899
    [Abstract] [Full Text] [Related]

  • 5. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
    Jagannath K, Chaluvadi MR, Mullangi R, Mamidi NV, Srinivas NR.
    Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
    [Abstract] [Full Text] [Related]

  • 6. The pharmacokinetics of pioglitazone in Thai healthy subjects.
    Wittayalertpanya S, Chompootaweep S, Thaworn N.
    J Med Assoc Thai; 2006 Dec; 89(12):2116-22. PubMed ID: 17214065
    [Abstract] [Full Text] [Related]

  • 7. Effect of multiple doses of montelukast on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in humans.
    Kim KA, Park PW, Kim KR, Park JY.
    Br J Clin Pharmacol; 2007 Mar; 63(3):339-45. PubMed ID: 16981900
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S, Catz P, Creek MR, Wu B, Thomas D, Krogstad DJ, De D, Mirsalis JC, Green CE.
    Int J Toxicol; 2004 Mar; 23(3):179-89. PubMed ID: 15204721
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M, Wu WH, Look ZM, Silber BM, Yacobi A.
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [Abstract] [Full Text] [Related]

  • 10. Oral bioavailability and pharmacokinetics of the new insulin sensitizer DRF-2189 in Wistar rats.
    Jajoo HK, Mamidi RN, Vakkalanka SV, Sathyavageeswaran S, Katneni K, Ayalasomayajula PS, Rao BP, Lohray BB, Subramaniam S.
    Arzneimittelforschung; 1999 Feb; 49(2):133-6. PubMed ID: 10083982
    [Abstract] [Full Text] [Related]

  • 11. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.
    Song KH, Fasano A, Eddington ND.
    Int J Pharm; 2008 Mar 03; 351(1-2):8-14. PubMed ID: 17954018
    [Abstract] [Full Text] [Related]

  • 12. Effect of quercetin on the pharmacokinetics of rosiglitazone, a CYP2C8 substrate, in healthy subjects.
    Kim KA, Park PW, Kim HK, Ha JM, Park JY.
    J Clin Pharmacol; 2005 Aug 03; 45(8):941-6. PubMed ID: 16027405
    [Abstract] [Full Text] [Related]

  • 13. A prospective cross-over study comparing the pharmacokinetics of cyclosporine A and its metabolites after oral versus short-time intravenous cyclosporine A administration in pre-heart transplant patients.
    Lehle K, Kirchner GI, Rupprecht L, Gruber M, Birnbaum DE, Schmid FX, Preuner JG.
    Transplant Proc; 2007 Dec 03; 39(10):3323-8. PubMed ID: 18089380
    [Abstract] [Full Text] [Related]

  • 14. Reduced prehepatic extraction of nicardipine in the presence of pioglitazone in rats.
    Choi JS, Koh YY, Chung JH, Choi DH, Han HK.
    J Pharm Pharmacol; 2008 Oct 03; 60(10):1403-7. PubMed ID: 18812034
    [Abstract] [Full Text] [Related]

  • 15. [The effect of tetramethylpyrazine on the pharmacokinetics of intragastrically administered cyclosporine A in rats].
    Liu XL, Tang J, Song J, He J, Xu P, Peng WX.
    Yao Xue Xue Bao; 2006 Sep 03; 41(9):882-7. PubMed ID: 17111838
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of 9-nitro-20(S)-camptothecin in rats.
    Zhong DF, Li K, Xu JH, Du Y, Zhang YF.
    Acta Pharmacol Sin; 2003 Mar 03; 24(3):256-62. PubMed ID: 12617776
    [Abstract] [Full Text] [Related]

  • 17. Effect of probucol on the oral bioavailability of cyclosporine A.
    Sugimoto K, Sudoh T, Tsuruoka S, Yamamoto Y, Maezono S, Watanabe Y, Fujimura A.
    Eur J Pharm Sci; 2004 May 03; 22(1):71-7. PubMed ID: 15113585
    [Abstract] [Full Text] [Related]

  • 18. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats.
    Kuester RK, Sólyom AM, Rodriguez VP, Sipes IG.
    Toxicol Sci; 2007 Apr 03; 96(2):237-45. PubMed ID: 17234645
    [Abstract] [Full Text] [Related]

  • 19. Bioavailability and pharmacokinetic studies of eurycomanone from Eurycoma longifolia.
    Low BS, Ng BH, Choy WP, Yuen KH, Chan KL.
    Planta Med; 2005 Sep 03; 71(9):803-7. PubMed ID: 16206032
    [Abstract] [Full Text] [Related]

  • 20. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA, Absalón-Reyes JA, Novoa-Heckel G, de Lago A, Oliva I, Rodríguez Z, González-de la Parra M, Burke-Fraga V, Namur S.
    Clin Ther; 2007 Jun 03; 29(6):1146-52. PubMed ID: 17692728
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 39.